-
In 2023
7.4 billion1
R&D investment reached
(RMB)
-
10 +
Global technology innovation centers
-
-
- Leading Core technologies in various fields
Innovative drug:focus on therapeutic areas such as oncology,immunology, central nervous system, and chronic disease, and mainly strengthencore technology platforms such as small molecule, antibody/ADC, cell therapy,and RNA
Vaccine: platforms of bacterial vaccine + viral vaccine
Device: three major platforms of medical cosmetology +respiratory health + professional medical care
Research & application of OrientalLifestyle Aesthetics
Construction of the 4D technology innovation system: five senses ofconsumers + technology innovation R&D + creative design + technologyinnovation digitalization
Insurance: digital platformoptimizes customer experience throughout the life cycle
Intelligent travel: full-stack self-developed L2+ intelligentdriving software and hardware solutions
Industrial automation: leveraging digital twin, machine vision andother technologies accumulated for many years in the industry, AIGC largemodels are introduced to promote full intelligence and automation in theindustry
New energy: from traditional energy to the upstreamextension of new energy and new materials
-
- Innovative Technology Innovation Centers In Various Fields
Fosun Pharma Global R&D Center (national level)
Fosun Pharma North America R&D Headquarters
Fosun Pharma Academician Expert Workstation
Jiangsu Wanbang Recombinant Protein Drug Engineering Center
Jiangsu Wanbang Engineering Research Center for Diabetic Drugs
Chongqing Yao Pharma National-Local Joint Research Center for Lyophilized Preparations
Chongqing Pharmaceutical Research Institute
Liaoning AVANC Pharma Professional Technology Innovation Center for Tumor and Perioperative Drugs
Foshan Fosun Chancheng Hospital Tumor Precision Key Laboratory
Shanghai Henlius Global Innovation Center
Wansheng Technology Center (national level)
Sichuan Engineering Technology Center for Intelligent Brewing of Baiju
Tianjin Seagull High-Precision Mechanical Watch Enterprise Key Laboratory
Fosun Cosmetics Global Innovation Center (CNAS certified)
Yuyuan Foods & Dining Group Innovation Center
Fosun Wine & Spirits Global Innovation Center
Yuyuan Jewelry Creative House
Lanvin Group Fabric Innovation Center
Easun Technology Global R&D Center
……
1 It includes scientific research investment (expensed and capitalized), but excludes digitalization expenses.
-
HANSIZHUANG (serplulimab injection)
The self-developed and world's first monoclonal antibody drug targeting PD-1 for first-line treatment of extensive stage small cell lung cancer Approved for four indications in Chinese Mainland The first home-made anti-PD-1 mAb approved for marketing in Southeast Asian countries.
-
HANQUYOU (trastuzumab injection)
The first monoclonal antibody biosimilar approved in China and Europe
Sales and marketing in more than 40 countries & regions globally -
YI KAI DA (ejilunsai injection)
The first CAR-T cell therapy product approved for marketing in Chinese Mainland
Second-line indication approved in Chinese Mainland -
Domestic da Vinci Xi surgical system
The first home-made da Vinci Xi surgical robot was officially put into use
Successfully launched and commenced the localization and commercialization of da Vinci Xi surgical system -
Artesun® & Argesun®
Treated more than 68 million severe malaria patients
The second generation, Argesun®: the world’s first artesunate injectable presented with a single solvent system that received WHO PQ -
Remote medical service
Nearly 2 million remote medical service consultations by Fosun Insurance Portugal were recorded
-
Quantitative analysis of prepared dishes
Yuyuan Foods & Dining Group Innovation Center has been committed to the quantitative analysis technology of prepared dishes, leading the development of the first product standards in the prepared noodle industry
-
Precise and intelligent matching system of the vehicle body
Easun Technology’s self-developed 2.5D advanced sensor significantly improves transmission speed and response time through industry-academia-research collaboration